Flow‐cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B‐cell precursor acute lymphoblastic leukemia in trial AIEOP‐BFM‐ALL 2000

2018 ◽  
Vol 66 (5) ◽  
pp. e27590 ◽  
Author(s):  
Angela Schumich ◽  
Margarita Maurer‐Granofszky ◽  
Andishe Attarbaschi ◽  
Ulrike Pötschger ◽  
Barbara Buldini ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
B Cell ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Lymphoblastic Leukemia ◽  
Disease Monitoring ◽  
Cell Precursor ◽  
Flow Cytometric ◽  
Minimal Residual Disease Monitoring ◽  
Minimal Residual

scholarly journals Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia

2020 ◽  
Vol 61 (11) ◽  
pp. 2665-2673 ◽  
Author(s):  
Nicola Gökbuget ◽  
Gerhard Zugmaier ◽  
Hervé Dombret ◽  
Anthony Stein ◽  
Massimiliano Bonifacio ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
B Cell ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Lymphoblastic Leukemia ◽  
Cell Precursor ◽  
Minimal Residual
Sign in / Sign up

Export Citation Format

Share Document